ATE246180T1 - Benzofuranon-derivate und verfahren zu ihrer herstellung - Google Patents
Benzofuranon-derivate und verfahren zu ihrer herstellungInfo
- Publication number
- ATE246180T1 ATE246180T1 AT98900226T AT98900226T ATE246180T1 AT E246180 T1 ATE246180 T1 AT E246180T1 AT 98900226 T AT98900226 T AT 98900226T AT 98900226 T AT98900226 T AT 98900226T AT E246180 T1 ATE246180 T1 AT E246180T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- benzofuranone
- derivatives
- present
- benzofuranone derivatives
- Prior art date
Links
- ACZGCWSMSTYWDQ-UHFFFAOYSA-N 3h-1-benzofuran-2-one Chemical class C1=CC=C2OC(=O)CC2=C1 ACZGCWSMSTYWDQ-UHFFFAOYSA-N 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 abstract 2
- -1 benzofuranone compound Chemical class 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1599197 | 1997-01-14 | ||
| JP22556597A JP3783810B2 (ja) | 1997-01-14 | 1997-08-08 | 新規ベンゾフラノン誘導体及びその製造方法 |
| PCT/JP1998/000090 WO1998030556A1 (en) | 1997-01-14 | 1998-01-13 | Novel benzofuranone derivatives and process for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE246180T1 true ATE246180T1 (de) | 2003-08-15 |
Family
ID=26352227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98900226T ATE246180T1 (de) | 1997-01-14 | 1998-01-13 | Benzofuranon-derivate und verfahren zu ihrer herstellung |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6143779A (de) |
| EP (1) | EP0902022B1 (de) |
| JP (1) | JP3783810B2 (de) |
| KR (1) | KR100293907B1 (de) |
| CN (1) | CN1173964C (de) |
| AT (1) | ATE246180T1 (de) |
| AU (1) | AU717159B2 (de) |
| CA (1) | CA2248953C (de) |
| DE (1) | DE69816731T2 (de) |
| DK (1) | DK0902022T3 (de) |
| ES (1) | ES2203921T3 (de) |
| HU (1) | HUP9901616A3 (de) |
| IL (1) | IL126137A (de) |
| NO (1) | NO319608B1 (de) |
| NZ (1) | NZ331857A (de) |
| PT (1) | PT902022E (de) |
| RU (1) | RU2152391C1 (de) |
| WO (1) | WO1998030556A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4166433B2 (ja) * | 1997-09-11 | 2008-10-15 | 第一製薬株式会社 | ホルモン依存性疾患治療剤 |
| RU2285696C2 (ru) * | 2002-08-21 | 2006-10-20 | Шицзячжуан Фарма, Груп Чжунци Фармасьютикал Текнолоджи (Шицзячжуан) Ко., Лтд. | Комплексы включения бутилфталида с циклодекстрином или его производными, способ их получения и их применение |
| US7754709B2 (en) | 2003-06-10 | 2010-07-13 | Solvay Pharmaceuticals Bv | Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds |
| US7465739B2 (en) | 2003-06-10 | 2008-12-16 | Solvay Pharmaceuticals B.V. | Compounds and their use in therapy |
| US20060014812A1 (en) * | 2004-07-14 | 2006-01-19 | Player Mark R | Use of estrogen related receptor-modulating aryl ethers |
| GB0513702D0 (en) | 2005-07-04 | 2005-08-10 | Sterix Ltd | Compound |
| US8158791B2 (en) * | 2005-11-10 | 2012-04-17 | Msd K.K. | Aza-substituted spiro derivatives |
| EP1990335A4 (de) * | 2006-03-02 | 2009-11-11 | Astellas Pharma Inc | 17-beta-hsd-typ-5-inhibitor |
| US8080540B2 (en) | 2006-09-19 | 2011-12-20 | Abbott Products Gmbh | Therapeutically active triazoles and their use |
| WO2009028418A1 (ja) | 2007-08-24 | 2009-03-05 | Sapporo Medical University | シクロスポリンａ結合タンパク質 |
| GB0722779D0 (en) | 2007-11-20 | 2008-01-02 | Sterix Ltd | Compound |
| WO2009097515A2 (en) * | 2008-01-30 | 2009-08-06 | Wyeth | [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| EP2300460A1 (de) * | 2008-05-28 | 2011-03-30 | Wyeth LLC | 3-substituierte 1h-indolverbindungen, ihre verwendung als mtor-kinase- und pi3-kinase-inhibitoren und ihre synthese |
| WO2009155052A1 (en) * | 2008-05-28 | 2009-12-23 | Wyeth | 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| US9540322B2 (en) | 2008-08-18 | 2017-01-10 | Yale University | MIF modulators |
| PE20110368A1 (es) * | 2008-08-18 | 2011-06-13 | Univ Yale | Moduladores de mif |
| US9156827B2 (en) | 2010-04-30 | 2015-10-13 | The University Of Tokyo | Anticancer agent |
| CN111801097A (zh) * | 2018-01-22 | 2020-10-20 | 肯塔基大学研究基金会 | 半合成噢哢及其使用方法 |
| CN115925665B (zh) * | 2022-12-09 | 2024-06-25 | 中国药科大学 | 一种pde4抑制剂及其应用 |
| CN117756761B (zh) * | 2023-12-14 | 2024-06-21 | 酒泉亚佳化学有限公司 | 一种苯并呋喃酮衍生物及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3975380A (en) * | 1974-06-03 | 1976-08-17 | Smithkline Corporation | Substituted aurones |
| RU2032683C1 (ru) * | 1991-07-02 | 1995-04-10 | Андрейчиков Юрий Сергеевич | 2-метил-5-метокси-3-метоксалилацетобензофуран, проявляющий противовирусную активность в отношении вируса гриппа типа а и в |
| US5354861A (en) * | 1992-11-04 | 1994-10-11 | National University Of Singapore | 2-(benzyl)-3-arylbenzofurans as antitumour and hypocholesterolemic agents |
| JP3872834B2 (ja) * | 1996-03-04 | 2007-01-24 | 第一製薬株式会社 | メイラード反応抑制剤 |
-
1997
- 1997-08-08 JP JP22556597A patent/JP3783810B2/ja not_active Expired - Fee Related
-
1998
- 1998-01-13 PT PT98900226T patent/PT902022E/pt unknown
- 1998-01-13 CN CNB988001365A patent/CN1173964C/zh not_active Expired - Fee Related
- 1998-01-13 NZ NZ331857A patent/NZ331857A/en unknown
- 1998-01-13 AT AT98900226T patent/ATE246180T1/de not_active IP Right Cessation
- 1998-01-13 AU AU53436/98A patent/AU717159B2/en not_active Ceased
- 1998-01-13 US US09/142,666 patent/US6143779A/en not_active Expired - Fee Related
- 1998-01-13 DK DK98900226T patent/DK0902022T3/da active
- 1998-01-13 RU RU98118569/04A patent/RU2152391C1/ru not_active IP Right Cessation
- 1998-01-13 CA CA002248953A patent/CA2248953C/en not_active Expired - Fee Related
- 1998-01-13 EP EP98900226A patent/EP0902022B1/de not_active Expired - Lifetime
- 1998-01-13 KR KR1019980707198A patent/KR100293907B1/ko not_active Expired - Fee Related
- 1998-01-13 DE DE69816731T patent/DE69816731T2/de not_active Expired - Fee Related
- 1998-01-13 ES ES98900226T patent/ES2203921T3/es not_active Expired - Lifetime
- 1998-01-13 WO PCT/JP1998/000090 patent/WO1998030556A1/ja not_active Ceased
- 1998-01-13 HU HU9901616A patent/HUP9901616A3/hu unknown
- 1998-01-13 IL IL126137A patent/IL126137A/en not_active IP Right Cessation
- 1998-09-11 NO NO19984195A patent/NO319608B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10259182A (ja) | 1998-09-29 |
| EP0902022A1 (de) | 1999-03-17 |
| KR20000064582A (ko) | 2000-11-06 |
| IL126137A0 (en) | 1999-05-09 |
| IL126137A (en) | 2006-08-01 |
| CN1217719A (zh) | 1999-05-26 |
| EP0902022A4 (de) | 2002-01-23 |
| NZ331857A (en) | 2000-02-28 |
| NO984195L (no) | 1998-10-26 |
| NO984195D0 (no) | 1998-09-11 |
| US6143779A (en) | 2000-11-07 |
| HUP9901616A1 (hu) | 2001-04-28 |
| DE69816731T2 (de) | 2004-06-03 |
| CA2248953A1 (en) | 1998-07-16 |
| HUP9901616A3 (en) | 2001-05-28 |
| RU2152391C1 (ru) | 2000-07-10 |
| PT902022E (pt) | 2003-12-31 |
| WO1998030556A1 (en) | 1998-07-16 |
| CN1173964C (zh) | 2004-11-03 |
| ES2203921T3 (es) | 2004-04-16 |
| KR100293907B1 (ko) | 2001-09-17 |
| DK0902022T3 (da) | 2003-11-24 |
| NO319608B1 (no) | 2005-08-29 |
| JP3783810B2 (ja) | 2006-06-07 |
| AU5343698A (en) | 1998-08-03 |
| CA2248953C (en) | 2003-09-09 |
| DE69816731D1 (de) | 2003-09-04 |
| AU717159B2 (en) | 2000-03-16 |
| EP0902022B1 (de) | 2003-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE246180T1 (de) | Benzofuranon-derivate und verfahren zu ihrer herstellung | |
| BG105177A (en) | Novel substituted pyrazole derivatives | |
| HK59397A (en) | Paroxetine hydrochloride anhydrate substantially free of bound organic solvent | |
| MY138525A (en) | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | |
| ATE151764T1 (de) | Neue benzopyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltenden zubereitungen | |
| BR9909844A (pt) | Processo para sintetizar um composto, e, composto. | |
| DE69113155D1 (de) | 17-beta-substituierte-4-aza-5-alpha-androstan-3-one-derivate und verfahren zu ihrer herstellung. | |
| DE50011034D1 (de) | N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE69912618D1 (de) | NEUE THIENO[2,3-d]PYRIMIDINDIONE, VERFAHREN FÜR IHRE HERSTELLUNG UND IHRE VERWENDUNG IN DER THERAPIE | |
| ATE277899T1 (de) | 8-8,6-6 und 6-8 catechin und epicatechin dimere und verfahren zu ihrer herstellung | |
| ATE334110T1 (de) | Neue tetralon-oder benzopyranon-derivate und ein verfahren zu ihrer herstellung | |
| ATE123492T1 (de) | Benzocycloalkylaminopyridinamine und verwandte verbindungen, verfahren zu ihrer herstellung, zwischenverbindungen und ihre verwendung als arzneimittel. | |
| DE69630609D1 (de) | Neue wasserlösliche fluoroethylcamptothecin-derivate und ein verfahren zu ihrer herstellung | |
| DE3774273D1 (de) | Chinazolin-derivat, verfahren zu dessen herstellung und mittel zur behandlung von cerebraler disfunktion als aktiver inhaltsstoff. | |
| ATE214051T1 (de) | Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| ATE165822T1 (de) | Chinolin-4-carbonylguanidin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE277887T1 (de) | Verfahren zur herstellung von 1,4-bis((2- (dimethylamino)ethyl amino)-5,8- dihydroxyanthracene-9,10-dion | |
| ATE267832T1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
| ATE226585T1 (de) | Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen | |
| PT1246790E (pt) | Bases de mannich de 1- e 2-naftol substituido | |
| DE69500198D1 (de) | Zns mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen | |
| DE69511449D1 (de) | Octahydro-2-Naphthalincarbonsäure-Derivate, ihre Herstellung und Verwendung | |
| ATE183512T1 (de) | Kardioaktive 17-hydroxyiminoalkyl- und 17- hydroxyiminomethylalkenyl-steroid-derivate, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon | |
| ATE215561T1 (de) | Methylsulfomycin 1, verfahren zu dessen herstellung und verwendung | |
| WO2003087035A8 (en) | 2,5-bis-diamine-'1,4! benzoquinone derivatives for the treatment of alzheimer's disease a process for their preparation and intermediates therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0902022 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |